SOW
HRTX icon

State of Wyoming’s Heron Therapeutics HRTX Stock Holding History

State of Wyoming’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,618
Closed -$40.5K – 2070
2026
Q1 		$40.5K Sell
50,618
-8,006
-14% -$9.28K ﹤0.01% 1575
2025
Q4 		$76.2K Buy
+58,624
New +$72.4K 0.01% 1373
2025
Q1 		– Sell
-29,736
Closed -$45.5K – 1735
2024
Q4 		$45.5K Buy
29,736
+25,321
+574% +$41K 0.01% 1459
2024
Q3 		$8.79K Sell
4,415
-28,312
-87% -$67.6K ﹤0.01% 1616
2024
Q2 		$115K Sell
32,727
-23,347
-42% -$71.7K 0.02% 942
2024
Q1 		$155K Sell
56,074
-30,088
-35% -$75.6K 0.03% 753
2023
Q4 		$146K Buy
86,162
+63,511
+280% +$69.9K 0.03% 758
2023
Q3 		$23.3K Sell
22,651
-1,373
-6% -$1.95K 0.01% 1488
2023
Q2 		$27.9K Buy
+24,024
New +$42.8K 0.01% 1341
2022
Q2 		– Sell
-525
Closed -$3K – 1991
2022
Q1 		$3K Buy
525
+88
+20% +$644 ﹤0.01% 1683
2021
Q4 		$4K Sell
437
-23
-5% -$235 ﹤0.01% 1735
2021
Q3 		$5K Sell
460
-43
-9% -$524 ﹤0.01% 1087
2021
Q2 		$8K Buy
503
+267
+113% +$4.25K 0.01% 1036
2021
Q1 		$4K Buy
+236
New +$4.21K 0.01% 447

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

State of Wyoming's HRTX Position: Q2 2026 in Review

State of Wyoming sold out of Heron Therapeutics (HRTX) in Q2 2026, closing a stake of 50,618 shares — an estimated $40.5K sold.

State of Wyoming first reported a position in HRTX in Q1 2021 and held it in 14 quarters. The position peaked at $155K in Q1 2024. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • State of Wyoming reported no remaining Heron Therapeutics position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 50,618 Heron Therapeutics shares in Q2 2026, an estimated $40.5K.
  • State of Wyoming first reported a position in Heron Therapeutics in Q1 2021 and held it in 14 quarters.
  • State of Wyoming's Heron Therapeutics position peaked at $155K in Q1 2024.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.